• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.从携带易感性突变的多个病例家系估计外显率:“基因型限制似然”(GRL)方法的扩展。
Eur J Hum Genet. 2011 Feb;19(2):173-9. doi: 10.1038/ejhg.2010.158. Epub 2010 Oct 6.
2
Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.当确诊取决于基因型和发病年龄时,利用回顾性似然法从家系数据估计外显率。
Genet Epidemiol. 2004 Sep;27(2):109-17. doi: 10.1002/gepi.20007.
3
Estimating cancer risk in HNPCC by the GRL method.用GRL方法评估遗传性非息肉病性结直肠癌的癌症风险。
Eur J Hum Genet. 2007 Aug;15(8):831-6. doi: 10.1038/sj.ejhg.5201843. Epub 2007 May 2.
4
Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.用于估计疾病易感性基因罕见突变外显率的最优设计。
Genet Epidemiol. 2003 Apr;24(3):173-80. doi: 10.1002/gepi.10219.
5
Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model.使用渐进三状态模型估计林奇综合征家族中的连续癌症风险。
Stat Med. 2014 Feb 20;33(4):618-38. doi: 10.1002/sim.5938. Epub 2013 Aug 15.
6
First estimates of diffuse gastric cancer risks for carriers of germline pathogenic variants.遗传性种系致病性变异携带者弥漫性胃癌风险的初步估计。
J Med Genet. 2022 Dec;59(12):1189-1195. doi: 10.1136/jmg-2022-108740. Epub 2022 Aug 29.
7
Estimating the penetrance of pathogenic gene variants in families with missing pedigree information.估计具有缺失家系信息的家族中致病性基因突变的外显率。
Stat Methods Med Res. 2019 Oct-Nov;28(10-11):2924-2936. doi: 10.1177/0962280218791338. Epub 2018 Aug 3.
8
Estimating disease risk associated with mutated genes in family-based designs.在基于家系的研究设计中评估与突变基因相关的疾病风险。
Hum Hered. 2008;66(4):238-51. doi: 10.1159/000143406. Epub 2008 Jul 9.
9
Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.犹他州一个大家族中单个BRCA1基因突变导致的癌症风险。
Fam Cancer. 2007;6(1):63-71. doi: 10.1007/s10689-006-9106-8.
10
A nonparametric method for penetrance function estimation.一种用于外显率函数估计的非参数方法。
Genet Epidemiol. 2009 Jan;33(1):38-44. doi: 10.1002/gepi.20354.

引用本文的文献

1
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.TUMOSPEC:一项针对通过多基因检测面板鉴定出预测致病变异的遗传性乳腺癌和卵巢癌家族的全国性研究。
Cancers (Basel). 2021 Jul 21;13(15):3659. doi: 10.3390/cancers13153659.
2
New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.子宫内膜癌的新分类:基于基因组的分类在研究和临床护理中的发展及潜在应用。
Gynecol Oncol Res Pract. 2016 Dec 13;3:14. doi: 10.1186/s40661-016-0035-4. eCollection 2016.

本文引用的文献

1
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.林奇综合征中 MLH1、MSH2 和 MSH6 基因种系突变与癌症风险的相关性。
JAMA. 2011 Jun 8;305(22):2304-10. doi: 10.1001/jama.2011.743.
2
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.林奇综合征患者结直肠癌和子宫内膜癌风险的计算。
Gastroenterology. 2009 Nov;137(5):1621-7. doi: 10.1053/j.gastro.2009.07.039. Epub 2009 Jul 18.
3
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.《2007年4月乳腺癌风险、遗传学与风险管理国际共识会议论文集》
Breast J. 2009 Jan-Feb;15(1):4-16. doi: 10.1111/j.1524-4741.2008.00665.x.
4
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.PEL:一种用于从未因家族病史而筛选的家系数据中估计年龄依赖性遗传疾病风险的无偏方法。
Genet Epidemiol. 2009 Jul;33(5):379-85. doi: 10.1002/gepi.20390.
5
Estimating disease risk associated with mutated genes in family-based designs.在基于家系的研究设计中评估与突变基因相关的疾病风险。
Hum Hered. 2008;66(4):238-51. doi: 10.1159/000143406. Epub 2008 Jul 9.
6
Cancer incidence and mortality in France over the period 1980-2005.1980年至2005年期间法国的癌症发病率和死亡率。
Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-175. doi: 10.1016/j.respe.2008.03.117. Epub 2008 Jun 10.
7
The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.林奇综合征患者发生结肠外、子宫内膜外癌症的风险。
Int J Cancer. 2008 Jul 15;123(2):444-449. doi: 10.1002/ijc.23508.
8
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.常见的乳腺癌易感等位基因与BRCA1和BRCA2突变携带者的乳腺癌风险相关。
Am J Hum Genet. 2008 Apr;82(4):937-48. doi: 10.1016/j.ajhg.2008.02.008. Epub 2008 Mar 20.
9
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.RAD51基因135G→C突变改变BRCA2突变携带者患乳腺癌的风险:19项研究的综合分析结果
Am J Hum Genet. 2007 Dec;81(6):1186-200. doi: 10.1086/522611. Epub 2007 Oct 16.
10
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.遗传性结直肠癌综合征:分子遗传学、遗传咨询、诊断与管理
Fam Cancer. 2008;7(1):27-39. doi: 10.1007/s10689-007-9165-5. Epub 2007 Nov 13.

从携带易感性突变的多个病例家系估计外显率:“基因型限制似然”(GRL)方法的扩展。

Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

机构信息

INRA-GABI, Jouy-en-Josas, France.

出版信息

Eur J Hum Genet. 2011 Feb;19(2):173-9. doi: 10.1038/ejhg.2010.158. Epub 2010 Oct 6.

DOI:10.1038/ejhg.2010.158
PMID:20924409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3025788/
Abstract

Some diseases are due to germline mutations in predisposing genes, such as cancer family syndromes. Precise estimation of the age-specific cumulative risk (penetrance) for mutation carriers is essential for defining prevention strategies. The genotype-restricted likelihood (GRL) method is aimed at estimating penetrance from multiple case families with such a mutation. In this paper, we proposed an extension of the GRL to account for multiple trait disease and to allow for a parent-of-origin effect. Using simulations of pedigrees, we studied the properties of this method and the effect of departures from underlying hypotheses, misspecification of disease incidence in the general population or misspecification of the index case, and penetrance heterogeneity. In contrast with the previous version of the GRL, accounting for multiple trait disease allowed unbiased estimation of penetrance. We also showed that accounting for a parent-of-origin effect allowed a powerful test for detecting this effect. We found that the GRL method was robust to misspecification of disease incidence in the population, but that misspecification of the index case induced a bias in some situations for which we proposed efficient corrections. When ignoring heterogeneity, the penetrance estimate was biased toward that of the highest risk individuals. A homogeneity test performed by stratifying the families according to the number of affected members was shown to have low power and seems useless for detecting such heterogeneity. These extensions are essential to better estimate the risk of diseases and to provide valid recommendations for the management of patients.

摘要

一些疾病是由于易感基因的种系突变引起的,例如癌症家族综合征。精确估计突变携带者的特定年龄累积风险(外显率)对于定义预防策略至关重要。基因型限制似然(GRL)方法旨在从具有此类突变的多个病例家族中估计外显率。在本文中,我们提出了一种扩展 GRL 的方法,以考虑多疾病性状,并允许存在亲本来源效应。通过对家系进行模拟,我们研究了该方法的性质以及与基本假设的偏离、一般人群中疾病发病率的误指定或索引病例的误指定以及外显率异质性的影响。与 GRL 的先前版本相比,考虑多疾病性状允许对外显率进行无偏估计。我们还表明,考虑亲本来源效应可以对检测这种效应进行强有力的检验。我们发现,GRL 方法对人群中疾病发病率的误指定具有稳健性,但在某些情况下,索引病例的误指定会导致偏差,我们为此提出了有效的校正方法。当忽略异质性时,外显率估计值会偏向风险最高的个体。通过根据受影响成员的数量对家庭进行分层来进行同质性检验,其功效较低,似乎对于检测这种异质性无用。这些扩展对于更好地估计疾病风险以及为患者管理提供有效的建议至关重要。